These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11371362)

  • 1. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.
    Cariappa A; Tang M; Parng C; Nebelitskiy E; Carroll M; Georgopoulos K; Pillai S
    Immunity; 2001 May; 14(5):603-15. PubMed ID: 11371362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.
    Martin F; Kearney JF
    Immunity; 2000 Jan; 12(1):39-49. PubMed ID: 10661404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen receptor proximal signaling in splenic B-2 cell subsets.
    Li X; Martin F; Oliver AM; Kearney JF; Carter RH
    J Immunol; 2001 Mar; 166(5):3122-9. PubMed ID: 11207264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
    Debnath I; Roundy KM; Weis JJ; Weis JH
    Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of marginal zone B cell development in the mouse with limited B cell diversity: role of the antigen receptor signals in the recruitment of B cells to the marginal zone.
    Kanayama N; Cascalho M; Ohmori H
    J Immunol; 2005 Feb; 174(3):1438-45. PubMed ID: 15661902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
    Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
    J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells.
    Nündel K; Busto P; Debatis M; Marshak-Rothstein A
    J Leukoc Biol; 2013 Nov; 94(5):865-75. PubMed ID: 23804807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk.
    Ellmeier W; Jung S; Sunshine MJ; Hatam F; Xu Y; Baltimore D; Mano H; Littman DR
    J Exp Med; 2000 Dec; 192(11):1611-24. PubMed ID: 11104803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.
    Kouro T; Nagata K; Takaki S; Nisitani S; Hirano M; Wahl MI; Witte ON; Karasuyama H; Takatsu K
    Int Immunol; 2001 Apr; 13(4):485-93. PubMed ID: 11282988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S; Hendriks RW
    J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aiolos regulates B cell activation and maturation to effector state.
    Wang JH; Avitahl N; Cariappa A; Friedrich C; Ikeda T; Renold A; Andrikopoulos K; Liang L; Pillai S; Morgan BA; Georgopoulos K
    Immunity; 1998 Oct; 9(4):543-53. PubMed ID: 9806640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling.
    Hoek KL; Carlesso G; Clark ES; Khan WN
    J Immunol; 2009 Nov; 183(9):5630-43. PubMed ID: 19843948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
    Fearon DT
    Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal zone B cells transport IgG3-immune complexes to splenic follicles.
    Zhang L; Ding Z; Xu H; Heyman B
    J Immunol; 2014 Aug; 193(4):1681-9. PubMed ID: 25015822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.